Admission Date:  [**2120-2-8**]              Discharge Date:   [**2120-2-13**]  Date of Birth:  [**2035-9-16**]             Sex:   M  Service: MEDICINE  Allergies: Rituxan  Attending:[**First Name3 (LF) 3963**] Chief Complaint: Dyspnea   Major Surgical or Invasive Procedure: [**2120-2-8**] Rituximab infusion [**2120-2-9**] Bendamustine, cycle one, 1st dose [**2120-2-10**] Bendamustin, cycle one, 2nd dose   History of Present Illness: The patient is an 84 year old male with lymphoplasmacytic lymphoma s/p four weekly doses of Rituxan in [**7-/2119**], with recent admission c/b pericardial effusion and pleural effusion (transudative s/p thoracentesis) who presents from rehabilitation with shortness of breath.
During that admission, the patient presented with new-onset dyspnea, and was noted to have a pericardial effusion with tamponade physiology.
He was started on a nitro gtt and initiated on BiPaP.
Denies chest pain, chest pressure, palpitations, or weakness.
Patient started on Rituximab - Rituximab 4 weekly doses [**2119-7-7**] .
PSgHx: - Cholecystectomy - Excision of scalp skin cancer  Social History: Single.
Family History: Brother died of pulmonary embolism  Physical Exam: Admission Physical Exam: Vitals:  76  149/68  23  94%RA General: Alert, oriented, no acute distress HEENT: MMM, oropharynx clear Neck: JVP elevated to 3 cm above sternal angle, no LAD Lungs: Crackles at left base, Diminished at R base, no wheeze CV: Regular rate and rhythm, normal S1 + S2, no m/r/g Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly Ext: warm, well perfused, 2+ edema b/l .
Patient continued chemotherapy on the floor.
Right pleural effusion: On chest x-ray on admission, this was noted to be increased from prior.
IP was consulted to assess possible drainage of effusion, however they felt it was not loculated and deferred the tap with plan to reassess.
Lymphoplasmacytic lymphoma: Disease appeared to be controlled after 4 cycles of rituxan in [**Month (only) 116**], though concern that pleural and pericardial effusions could be related to underlying disease.
Rituxan was started [**2120-1-28**], complicated by a tranfusion reaction with afib w RVR, hypotension.
After leaving the ICU, the patient received two doses of bendamustine, without incident.
He will continue bendamustine therapy.
At the time of discharge, the patient had human anti-chimeric and anti-murine antibodies sent out for testing to evaluate for allergy to rituxan.
Patient was also started on allopurinol 150 mg PO daily for tumor lysis syndrome.
Hypertension: Initially in 170s in ED, started on nitro gtt prior to arrival in the ICU.
He was restarted on captopril and metoprolol and weaned of the nitro gtt.
Blood pressure was well-controlled after increase in captopril and diuresis.
Continued on his home metoprolol .
Continued on his home dose of levetiracetam 500 mg PO BID .
# Communication: Patient # Code: Full (discussed with patient)  Medications on Admission: Medications: (per recent d/c summary) - fluoxetine 40 mg PO once a day - levetiracetam 500 mg PO BID - omeprazole 20 mg PO once a day.
- oxybutynin chloride 5 mg PO BID - docusate sodium 100 mg PO BID - ferrous sulfate 300  mg PO BID - albuterol sulfate 2.5 mg /3 mL (0.083 %) Solution Q6H prn - senna 8.6 mg PO BID as needed for constipation.
- metoprolol succinate 50 mg PO once a day.
- captopril 25 mg PO Q8H - olanzapine 5 mg PO QHS as needed for insomnia.
Discharge Medications: 1. levetiracetam 500 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
2. fluoxetine 20 mg Capsule Sig: Two (2) Capsule PO DAILY (Daily).
3. omeprazole 20 mg Capsule, Delayed Release(E.C.)
4. oxybutynin chloride 5 mg Tablet Sig: One (1) Tablet PO twice a day.
5. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
6. furosemide 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Disp:*30 Tablet(s)* Refills:*0* 7. albuterol sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization Sig: One (1) soln Inhalation every six (6) hours.
8. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed for constipation.
9. metoprolol succinate 50 mg Tablet Extended Release 24 hr Sig: One (1) Tablet Extended Release 24 hr PO once a day.
10. captopril 25 mg Tablet Sig: Three (3) Tablet PO TID (3 times a day).
Disp:*270 Tablet(s)* Refills:*0* 11. olanzapine 5 mg Tablet Sig: One (1) Tablet PO qhs prn as needed for insomnia.
12. allopurinol 300 mg Tablet Sig: 0.5 Tablet PO DAILY (Daily).
Disp:*15 Tablet(s)* Refills:*0* 13. ferrous sulfate 324 mg (65 mg iron) Tablet, Delayed Release (E.C.)
You improved after fluid was taken off with intravenous diuretic medications.
While you were in the hospital, you received new chemotherapy with bendamustine.
You tolerated this well, and will continue this treatment at your outpatient visits.
START furosemide 20 mg by mouth daily 2.)
START allopurinol 150 mg by mouth daily 3.)
INCREASE captopril to 75 mg by mouth three times per day  Please continue to take all of your other medications as you had prior to your admission.
